EMAIL THIS PAGE TO A FRIEND

Clinical cancer research : an official journal of the American Association for Cancer Research

Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.


PMID 24721646

Abstract

Triple-negative breast cancers (TNBC) are defined by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (ERBB2/HER2). Although initially responsive to chemotherapy, most recurrent TNBCs develop resistance, resulting in disease progression. Autophagy is a lysosome-mediated degradation and recycling process that can function as an adaptive survival response during chemotherapy and contribute to chemoresistance. Our goal was to determine whether autophagy inhibition improves treatment efficacy in TNBC cells in tumors either sensitive or refractory to anthracyclines. We used in vitro and in vivo models of TNBC using cell lines sensitive to epirubicin and other anthracyclines, as well as derivative lines, resistant to the same drugs. We assessed basal autophagy levels and the effects of chemotherapy on autophagy in parental and resistant cells. Applying various approaches to inhibit autophagy alone and in combination with chemotherapy, we assessed the effects on cell viability in vitro and tumor growth rates in vivo. We demonstrated that epirubicin induced autophagic flux in TNBC cells. Epirubicin-resistant lines exhibited at least 1.5-fold increased basal autophagy levels and, when treated with autophagy inhibitors, showed a significant loss in viability, indicating dependence of resistant cells on autophagy for survival. Combination of epirubicin with the autophagy inhibitor hydroxychloroquine resulted in a significant reduction in tumor growth compared with monotherapy with epirubicin. Autophagy inhibition enhances therapeutic response in both anthracycline-sensitive and -resistant TNBC and may be an effective new treatment strategy for this disease.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1305642
ANTI-APG5 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
A0856
Anti-ATG5 (N-terminal) antibody produced in rabbit, affinity isolated antibody, PBS solution
GW22210F
Anti-ATG5 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB3500448
Anti-ATG5 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
HPA042973
Anti-ATG5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1407006
Anti-ATG7 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
A2856
Anti-ATG7 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA007639
Anti-ATG7 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410101
Anti-ATG7 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2701263
Anti-DCTN4 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2107220
Anti-DCTN4 antibody produced in rabbit, affinity isolated antibody
SAB2105017
Anti-DCTN4, (N-terminal) antibody produced in rabbit, affinity isolated antibody
HPA015737 Anti-EIF2AK3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2900917
Anti-EIF2AK3 antibody produced in rabbit, affinity isolated antibody
GW22005A Anti-GTF2H1 (ab1) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
GW22005B Anti-GTF2H1 (ab2) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
AV100811
Anti-GTF2H1 antibody produced in rabbit, IgG fraction of antiserum
SAB2104463
Anti-GTF2H1 antibody produced in rabbit, affinity isolated antibody
SAB4200361
Anti-LC3B antibody, Mouse monoclonal, clone LC3B-6, purified from hybridoma cell culture
SAB2700738
Anti-Map1lc3b antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3501065
Anti-MAP1LC3B antibody produced in rabbit, affinity isolated antibody
GW22431A Anti-NUP62 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
HPA005435
Anti-NUP62 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2101664
Anti-NUP62 antibody produced in rabbit, affinity isolated antibody
SAB1410438
Anti-NUP62 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB1306427
ANTI-PERK (N-TERM Q163) antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
P0073
Anti-PERK (N-terminal) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
1316004
Hydrocortisone, United States Pharmacopeia (USP) Reference Standard
C21H30O5
PHR1014
Hydrocortisone, Pharmaceutical Secondary Standard; Certified Reference Material
C21H30O5
31719
Hydrocortisone, VETRANAL, analytical standard
C21H30O5